Down 1.8% to $18.43, Pharmacyclics (NASDAQ:PCYC), is one of today's notable movers. The S&P is trading fractionally lower to 1,311 and the Dow is trading 0.4% lower to 12,609.
Pharmacyclics, Inc. is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer, atherosclerosis, and retinal disease. The Company's products are patented agents derived from its technology platform for designing and synthesizing energy-potentiating drugs.
There is potential upside of 6.7% for shares of Pharmacyclics based on a current price of $18.43 and an average consensus analyst price target of $19.67. Pharmacyclics shares have support at the 50-day moving average (MA) of $15.08 and additional support at the 200-day MA of $11.37.
Over the past year, Pharmacyclics has traded in a range of $4.75 to $19.46 and is now at $18.43, 288% above that low. The 200-day and 50-day moving averages have moved 1.66% higher and 2.82% higher over the past week, respectively.
